More than 120 medical research scientists in the field of inflammation converged at Hudson Institute today to share knowledge and find solutions for patients across a broad range of diseases.

Inflammation is the body’s first line of defence against infection or injury. However, chronic and misdirected inflammation can be at the root of many diseases.

By advancing our understanding of both healthy inflammation and chronic inflammation through research and clinical trials we are opening up new ways to help people suffering with a wide range of inflammation related disease.

Our scientists undertake research to develop and improve upon strategies to diagnose, prevent and treat inflammatory diseases, such as certain types of cancer, infectious diseases and autoimmune diseases.

Research Scientist Dr Nicole de Weerd commented, “There is so much to be gained from events such as today’s symposium, where we have been sharing as much information as possible and building networks to progress research outcomes,” she said.

Talking science

The theme of the symposium is ‘Talking science and fostering collaborations’, and researchers from Hudson Institute of Medical Research and the Walter and Eliza Hall Institute of Medical Research gathered to hear a series of presentations by post-doctoral students and senior laboratory heads.

“It’s a great opportunity for cross-institutional discussions and networking and for young scientists in the field to present their research to a wider scientific audience,” Dr de Weerd said.

The senior laboratory heads who are presenting are Professor Richard Ferrero, Dr Samuel Forster, Dr Michael Gantier, Professor Paul Hertzog and Professor Elizabeth Hartland.

While 16 post-doctoral students shared their work in 15-minute talks, which included talks by

• Belinda Thomas | TGFbeta exacerbates disease severity following IAV infection
• Kathleen McCaffrey | Endoplasmic reticulum stress and inflammation
• Tomalika Ulla | DNA damage by genotoxic agents impacts the cGAS-STING pathway
• Emily Gulliver | The Microbiome: How gut microbes can guide the development of novel therapeutics
• Jamie Gearing | Bioinformatics capabilities of CiiID
• Rebecca Ambrose | Inflammation and cell death in Salmonella infections
• Mohamed Saad | Uncovering the Pathophysiologic Role of ADAM17/IL-6 Trans-signalling in Lung Cancer and Cigarette Smoke Carcinogen-Induced Pancreatitis
• Michelle Chonwerawong | The protective role of NLRC5 in Helicobacter-induced gastric MALT lymphomagensesis

“It was great to see early career researchers presenting their data to a broader audience and to see the senior researchers challenged with the constraints of a three-minute thesis style presentation!” Dr de Weerd said.

Contact us

Hudson Institute communications
t: + 61 3 8572 2697
e: communications@hudson.org.au